Comparison of Different Hypotheses Regarding the Spread of Alzheimer's Disease Using Markov Random Fields and Multimodal Imaging.
暂无分享,去创建一个
Thomas Kirste | Harald Binder | Abdolreza Mohammadi | Martin Dyrba | Stefan J Teipel | Michel J Grothe | S. Teipel | T. Kirste | M. Grothe | M. Dyrba | H. Binder | A. Mohammadi | Abdolreza Mohammadi
[1] Bedda L. Rosario,et al. Basal Cerebral Metabolism May Modulate the Cognitive Effects of Aβ in Mild Cognitive Impairment: An Example of Brain Reserve , 2009, The Journal of Neuroscience.
[2] C. Jack,et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease , 1997, Neurology.
[3] G. Chételat,et al. Region-Specific Hierarchy between Atrophy, Hypometabolism, and β-Amyloid (Aβ) Load in Alzheimer's Disease Dementia , 2012, The Journal of Neuroscience.
[4] M. Ewers,et al. Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer's disease , 2014, Neurobiology of Aging.
[5] D. Drachman. The amyloid hypothesis, time to move on: Amyloid is the downstream result, not cause, of Alzheimer's disease , 2014, Alzheimer's & Dementia.
[6] M. Weiner,et al. Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia , 2011, Trends in Neurosciences.
[7] H. Rusinek,et al. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[8] Paul M. Thompson,et al. Staging Alzheimer's disease progression with multimodality neuroimaging , 2011, Progress in Neurobiology.
[9] Alan C. Evans,et al. Epidemic Spreading Model to Characterize Misfolded Proteins Propagation in Aging and Associated Neurodegenerative Disorders , 2014, PLoS Comput. Biol..
[10] Efstathios D. Gennatas,et al. Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome , 2012, Neuron.
[11] Damaris Zurell,et al. Collinearity: a review of methods to deal with it and a simulation study evaluating their performance , 2013 .
[12] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[13] Kristopher J Preacher,et al. On the practice of dichotomization of quantitative variables. , 2002, Psychological methods.
[14] Maurizio Corbetta,et al. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] C. Jack,et al. Comparison of 18F-FDG and PiB PET in Cognitive Impairment , 2009, Journal of Nuclear Medicine.
[16] M. Greicius,et al. Decoding subject-driven cognitive states with whole-brain connectivity patterns. , 2012, Cerebral cortex.
[17] Stefan J. Teipel,et al. The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment — Beyond classical regression , 2015, NeuroImage: Clinical.
[18] Alan C. Evans,et al. Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease. , 2006, Brain : a journal of neurology.
[19] Xiaoming Yuan,et al. The flare package for high dimensional linear regression and precision matrix estimation in R , 2020, J. Mach. Learn. Res..
[20] J. Hardy,et al. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.
[21] Olaf Sporns,et al. Structural Network Topology Revealed by White Matter Tractography in Cannabis Users: A Graph Theoretical Analysis , 2011, Brain Connect..
[22] C. Jack,et al. An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer disease , 2012, Annals of neurology.
[23] M. Weiner,et al. A Network Diffusion Model of Disease Progression in Dementia , 2012, Neuron.
[24] N. Foster,et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.
[25] Kewei Chen,et al. Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. , 2011, Archives of neurology.
[26] A. Drzezga,et al. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[27] Peter Stoeter,et al. Diagnostic utility of hippocampal size and mean diffusivity in amnestic MCI , 2007, Neurobiology of Aging.
[28] Te-Chun Hsieh,et al. Sex‐ and Age‐Related Differences in Brain FDG Metabolism of Healthy Adults: An SPM Analysis , 2012, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[29] Keith A. Johnson,et al. In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain , 2016, The Journal of Neuroscience.
[30] G L Shulman,et al. INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .
[31] Keith A. Johnson,et al. Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression. , 2015, Brain : a journal of neurology.
[32] A. Bokde,et al. Assessing neuronal networks: Understanding Alzheimer's disease , 2009, Progress in Neurobiology.
[33] C. Rowe,et al. Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism , 2008, The Lancet Neurology.
[34] J. Gunter,et al. Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease , 2012, Neurology.
[35] K. Wienhard,et al. Normal and pathological aging – findings of positron-emission-tomography , 1998, Journal of Neural Transmission.
[36] Stefan Teipel,et al. Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease , 2014, Neurobiology of Aging.
[37] C. Jack,et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.
[38] Li Shen,et al. Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort , 2009, Current Alzheimer research.
[39] Michael Weiner,et al. Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer's Disease. , 2015, Cell reports.
[40] S. Teipel,et al. Spatial patterns of atrophy, hypometabolism, and amyloid deposition in Alzheimer's disease correspond to dissociable functional brain networks , 2016, Human brain mapping.
[41] Sébastien Ourselin,et al. Head size, age and gender adjustment in MRI studies: a necessary nuisance? , 2010, NeuroImage.
[42] M. Greicius,et al. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI , 2004, Proc. Natl. Acad. Sci. USA.
[43] Bernard Ng,et al. Regional brain hypometabolism is unrelated to regional amyloid plaque burden. , 2015, Brain : a journal of neurology.
[44] Keith A. Johnson,et al. Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease , 2009, The Journal of Neuroscience.
[45] Charles DeCarli,et al. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. , 2015, Brain : a journal of neurology.
[46] N. Schuff,et al. Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection , 2015, The Lancet Neurology.
[47] Benjamin J. Shannon,et al. Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.
[48] M. Bobinski,et al. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease , 1999, Neuroscience.
[49] B. Miller,et al. Neurodegenerative Diseases Target Large-Scale Human Brain Networks , 2009, Neuron.
[50] Peng Yu,et al. Relationship of Hippocampal Volume to Amyloid Burden across Diagnostic Stages of Alzheimer's Disease , 2015, Dementia and Geriatric Cognitive Disorders.
[51] Jian Wang,et al. Alterations of whole-brain cortical area and thickness in mild cognitive impairment and Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.
[52] Lea T Grinberg,et al. Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment. , 2016, Cerebral cortex.
[53] Gereon R. Fink,et al. Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease , 2016, Annals of clinical and translational neurology.
[54] Nikos Komodakis,et al. Markov Random Field modeling, inference & learning in computer vision & image understanding: A survey , 2013, Comput. Vis. Image Underst..
[55] H. Heinsen,et al. Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease , 2013, Neurobiology of Aging.
[56] James Robert Brašić,et al. In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18) , 2010, Journal of Nuclear Medicine.
[57] S. Soriano,et al. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis , 2014, Ageing Research Reviews.
[58] Alex Becker,et al. In vivo characterization of the early states of the amyloid-beta network. , 2013, Brain : a journal of neurology.
[59] M. Reivich,et al. Labeled 2-deoxy-D-glucose analogs. 18F-labeled 2-deoxy-2-fluoro-D-glucose, 2-deoxy-2-fluoro-D-mannose and 14C-2-deoxy-2-fluoro-D-glucose , 1978 .
[60] R. Coleman,et al. Use of florbetapir-PET for imaging beta-amyloid pathology. , 2011, JAMA.
[61] R H Huesman,et al. Regional Cerebral Metabolic Alterations in Dementia of the Alzheimer Type: Positron Emission Tomography with [1818] Fluorodeoxyglucose , 1983, Journal of computer assisted tomography.
[62] Francis Eustache,et al. Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease , 2013, NeuroImage: Clinical.
[63] Michael W. Weiner,et al. Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects , 2015, Neurobiology of Aging.
[64] Maximilian Reiser,et al. White matter microstructure underlying default mode network connectivity in the human brain , 2010, NeuroImage.
[65] Stefan Teipel,et al. Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer’s disease? , 2016, European Journal of Nuclear Medicine and Molecular Imaging.
[66] Gemma C. Garriga,et al. Permutation Tests for Studying Classifier Performance , 2009, 2009 Ninth IEEE International Conference on Data Mining.
[67] Maximilian Reiser,et al. Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment , 2007, NeuroImage.
[68] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[69] Harald Hampel,et al. Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer's disease , 2012, Neurobiology of Aging.
[70] Yen-Hsiang Chang,et al. Amyloid Burden in the Hippocampus and Default Mode Network , 2015, Medicine.
[71] Zhiqiang Zhang,et al. Gender Differences of Brain Glucose Metabolic Networks Revealed by FDG-PET: Evidence from a Large Cohort of 400 Young Adults , 2013, PloS one.
[72] S. Teipel,et al. Multimodal analysis of functional and structural disconnection in Alzheimer's disease using multiple kernel SVM , 2015, Human brain mapping.
[73] Marine Fouquet,et al. Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease. , 2010, Brain : a journal of neurology.
[74] M N Rossor,et al. Intracranial volume and Alzheimer disease: evidence against the cerebral reserve hypothesis. , 2000, Archives of neurology.
[75] Paolo Maria Rossini,et al. Brain excitability and connectivity of neuronal assemblies in Alzheimer's disease: From animal models to human findings , 2012, Progress in Neurobiology.
[76] Maximilian Reiser,et al. Multivariate network analysis of fiber tract integrity in Alzheimer’s disease , 2007, NeuroImage.
[77] C. Stam. Modern network science of neurological disorders , 2014, Nature Reviews Neuroscience.
[78] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.
[79] John Ashburner,et al. A fast diffeomorphic image registration algorithm , 2007, NeuroImage.
[80] Martin Hallbeck,et al. Neuron-to-Neuron Transmission of Neurodegenerative Pathology , 2013, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[81] Trevor Hastie,et al. Learning the Structure of Mixed Graphical Models , 2015, Journal of computational and graphical statistics : a joint publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America.
[82] M N Rossor,et al. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease , 2001, Annals of neurology.
[83] Sébastien Ourselin,et al. Multiple Orderings of Events in Disease Progression , 2015, IPMI.
[84] W. Jagust,et al. Apolipoprotein E, Not Fibrillar β-Amyloid, Reduces Cerebral Glucose Metabolism in Normal Aging , 2012, The Journal of Neuroscience.
[85] Stefan J. Teipel,et al. Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects , 2014, Alzheimer's & Dementia.